Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $12,627 | 6 | 51.3% |
| Unspecified | $7,770 | 2 | 31.6% |
| Honoraria | $2,400 | 1 | 9.8% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,800 | 1 | 7.3% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Pharmaceuticals, Inc. | $7,770 | 2 | $0 (2020) |
| SANOFI US SERVICES INC. | $6,252 | 2 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $3,375 | 1 | $0 (2020) |
| PFIZER INC. | $2,400 | 1 | $0 (2021) |
| SANOFI PASTEUR INC. | $1,800 | 1 | $0 (2021) |
| Janssen Research & Development, LLC | $1,500 | 1 | $0 (2020) |
| Siemens Medical Solutions USA, Inc. | $900.00 | 1 | $0 (2022) |
| BAXTER HEALTHCARE | $600.00 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $900.00 | 1 | Siemens Medical Solutions USA, Inc. ($900.00) |
| 2021 | $4,200 | 2 | PFIZER INC. ($2,400) |
| 2020 | $18,897 | 6 | Regeneron Pharmaceuticals, Inc. ($7,770) |
| 2019 | $600.00 | 1 | BAXTER HEALTHCARE ($600.00) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2022 | Siemens Medical Solutions USA, Inc. | — | Consulting Fee | Cash or cash equivalent | $900.00 | General |
| 10/02/2021 | SANOFI PASTEUR INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,800.00 | General |
| 01/15/2021 | PFIZER INC. | — | Honoraria | Cash or cash equivalent | $2,400.00 | General |
| 12/23/2020 | SANOFI US SERVICES INC. | KEVZARA (Biological) | Consulting Fee | Cash or cash equivalent | $2,605.00 | General |
| Category: Immunology | ||||||
| 12/16/2020 | Teva Pharmaceuticals USA, Inc. | COPAXONE (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: Central Nervous System | ||||||
| 12/11/2020 | Regeneron Pharmaceuticals, Inc. | KEVZARA (Biological) | — | Cash or cash equivalent | $840.00 | Research |
| Study: An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID-19 • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/07/2020 | Regeneron Pharmaceuticals, Inc. | KEVZARA (Biological) | — | Cash or cash equivalent | $6,930.00 | Research |
| Study: An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID-19 • Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/03/2020 | SANOFI US SERVICES INC. | KEVZARA (Biological) | Consulting Fee | Cash or cash equivalent | $3,647.00 | General |
| Category: Immunology | ||||||
| 05/15/2020 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 04/03/2019 | BAXTER HEALTHCARE | Fluid Systems - Drug Delivery Systems (Biological) | Consulting Fee | Cash or cash equivalent | $600.00 | General |
| Category: Fluid Systems | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| An Adaptive Phase 2/3, Randomized, Double-Blind, Placebo-Controlled Study Assessing Efficacy and Safety of Sarilumab for Hospitalized Patients With COVID-19 | Regeneron Pharmaceuticals, Inc. | $7,770 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 14 | 36 | $18,082 | $6,159 |
| 2022 | 1 | 25 | 36 | $18,288 | $6,363 |
| 2021 | 2 | 55 | 102 | $47,832 | $16,455 |
| 2020 | 2 | 72 | 113 | $55,714 | $18,758 |
All Medicare Procedures & Services
6 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 14 | 36 | $18,082 | $6,159 | 34.1% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 25 | 36 | $18,288 | $6,363 | 34.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 41 | 83 | $43,207 | $14,844 | 34.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 19 | $4,625 | $1,612 | 34.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 54 | 91 | $50,324 | $16,846 | 33.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 18 | 22 | $5,390 | $1,912 | 35.5% |
About Dr. Mitchell Levy, MD
Dr. Mitchell Levy, MD is a Critical Care Medicine healthcare provider based in Providence, Rhode Island. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1396785325.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mitchell Levy, MD has received a total of $24,597 in payments from pharmaceutical and medical device companies, with $900.00 received in 2022. These payments were reported across 10 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($12,627).
As a Medicare-enrolled provider, Levy has provided services to 166 Medicare beneficiaries, totaling 287 services with total Medicare billing of $47,734. Data is available for 4 years (2020–2023), covering 6 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Location Providence, RI
- Active Since 06/07/2006
- Last Updated 07/26/2018
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1396785325
Products in Payments
- KEVZARA (Biological) $14,022
- COPAXONE (Drug) $3,375
- Fluid Systems - Drug Delivery Systems (Biological) $600.00
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Providence
Andrew Foderaro, M.d, M.D
Critical Care Medicine — Payments: $6,425
Leandro Ramirez, Md, Mha, MD, MHA
Critical Care Medicine — Payments: $3,359
Dr. Adeel Abbasi, Md, MD
Critical Care Medicine — Payments: $388.10
Nicholas Ward, Md, MD
Critical Care Medicine — Payments: $306.00
Mr. Daniel Fortin, Rn, RN
Critical Care Medicine — Payments: $187.16
Siobhan Bourget, Fnp, FNP
Critical Care Medicine — Payments: $179.25